| | Varia. | Varia. 5j. | Varia. 1 janv. | Varia. 1an | Varia. 3ans | Capi. (M$) |
 | REGENERON PHARMACEUTICALS, INC. | -1.25% | 7.53% | 4.38% | 27.70% | 116.17% | 71 026 |
| | | | | | | |
| GILEAD SCIENCES, INC. | 0.06% | 4.39% | -12.93% | -8.18% | -4.73% | 79 298 |
| VERTEX PHARMACEUTICALS | -3.62% | 7.40% | 14.91% | 17.57% | 49.56% | 64 540 |
 | WUXI APPTEC CO., LTD. | -3.07% | -4.90% | -18.77% | -28.24% | 181.56% | 41 409 |
| BIONTECH SE | -1.71% | 8.95% | -39.08% | -19.25% | --.--% | 38 169 |
 | GENMAB A/S | 0.00% | 3.20% | -19.16% | -7.36% | 84.23% | 19 651 |
 | ARGENX SE | -0.24% | 4.98% | -7.33% | 32.10% | 156.09% | 16 793 |
| BEIGENE, LTD. | -5.40% | 8.24% | -51.61% | -61.21% | -0.30% | 13 526 |
| NEUROCRINE BIOSCIENCES, INC. | -0.99% | 3.72% | -0.26% | -9.44% | 7.49% | 8 119 |
| LEGEND BIOTECH CORPORATION | -2.89% | 19.61% | -12.72% | 15.24% | --.--% | 6 274 |
| EXELIXIS, INC. | -5.80% | -1.76% | 6.62% | -19.93% | 0.83% | 6 251 |
| SAREPTA THERAPEUTICS, INC. | -3.97% | 9.19% | -23.96% | -15.93% | -43.72% | 5 991 |
| HALOZYME THERAPEUTICS, INC. | -3.28% | 16.39% | 6.94% | 1.51% | 175.46% | 5 924 |
| INTRA-CELLULAR THERAPIES, INC. | -1.53% | 9.59% | 11.77% | 56.67% | 367.63% | 5 518 |
 | BIOCON LIMITED | -4.54% | 1.08% | -11.56% | -16.59% | 23.32% | 5 170 |
| ASCENDIS PHARMA A/S | -3.34% | 10.14% | -36.07% | -37.74% | -29.72% | 4 799 |
| | | | | | | |
| | Moyenne | -2.69% | 6.68% | -12.88% | -6.72% | 74.44% | |
| | Moyenne pondérée par Capi. | -2.03% | 5.05% | -11.95% | -6.22% | 63.05% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
